Design and synthesis of dye-conjugated hepsin inhibitors

Kyul Kim, Hongmok Kwon, Doyoung Choi, Taehyeong Lim, Il Minn, Sang Hyun Son, Youngjoo Byun

Research output: Contribution to journalArticle

Abstract

Hepsin is a type II serine protease that is highly expressed in neoplastic prostate. It is an attractive biomarker for imaging metastatic prostate cancer because of its overexpression in advanced prostate cancer and the location of its active site on the cell surface. We designed and synthesized novel hepsin-targeted imaging probes by conjugating the hepsin-binding ligand with near-infrared (NIR) optical dyes. The Leu-Arg dipeptides, attached to BODIPY or SulfoCy7, exhibited strong hepsin-inhibitory activities with Ki values of 21 and 22 nM, respectively. Compound 2 showed selective uptake and retention in hepsin-overexpressing cells. This is the first report of hepsin-targeted optical probes with strong binding affinities and high selectivity over matriptase. Compound 2 has the potential to be used for developing hepsin-based imaging probes and be as a prototype molecule in the design of new hepsin inhibitors.

Original languageEnglish (US)
Article number102990
JournalBioorganic Chemistry
Volume89
DOIs
StatePublished - Aug 1 2019

Fingerprint

Coloring Agents
Imaging techniques
leucylarginine
Prostatic Neoplasms
hepsin
Dipeptides
Serine Proteases
Biomarkers
Prostate
Catalytic Domain
Ligands
Infrared radiation
Molecules

Keywords

  • BODIPY
  • Hepsin
  • Optical dye
  • SulfoCy7

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Drug Discovery
  • Organic Chemistry

Cite this

Kim, K., Kwon, H., Choi, D., Lim, T., Minn, I., Son, S. H., & Byun, Y. (2019). Design and synthesis of dye-conjugated hepsin inhibitors. Bioorganic Chemistry, 89, [102990]. https://doi.org/10.1016/j.bioorg.2019.102990

Design and synthesis of dye-conjugated hepsin inhibitors. / Kim, Kyul; Kwon, Hongmok; Choi, Doyoung; Lim, Taehyeong; Minn, Il; Son, Sang Hyun; Byun, Youngjoo.

In: Bioorganic Chemistry, Vol. 89, 102990, 01.08.2019.

Research output: Contribution to journalArticle

Kim, Kyul ; Kwon, Hongmok ; Choi, Doyoung ; Lim, Taehyeong ; Minn, Il ; Son, Sang Hyun ; Byun, Youngjoo. / Design and synthesis of dye-conjugated hepsin inhibitors. In: Bioorganic Chemistry. 2019 ; Vol. 89.
@article{d278a441897f422199e5bd4bde409726,
title = "Design and synthesis of dye-conjugated hepsin inhibitors",
abstract = "Hepsin is a type II serine protease that is highly expressed in neoplastic prostate. It is an attractive biomarker for imaging metastatic prostate cancer because of its overexpression in advanced prostate cancer and the location of its active site on the cell surface. We designed and synthesized novel hepsin-targeted imaging probes by conjugating the hepsin-binding ligand with near-infrared (NIR) optical dyes. The Leu-Arg dipeptides, attached to BODIPY or SulfoCy7, exhibited strong hepsin-inhibitory activities with Ki values of 21 and 22 nM, respectively. Compound 2 showed selective uptake and retention in hepsin-overexpressing cells. This is the first report of hepsin-targeted optical probes with strong binding affinities and high selectivity over matriptase. Compound 2 has the potential to be used for developing hepsin-based imaging probes and be as a prototype molecule in the design of new hepsin inhibitors.",
keywords = "BODIPY, Hepsin, Optical dye, SulfoCy7",
author = "Kyul Kim and Hongmok Kwon and Doyoung Choi and Taehyeong Lim and Il Minn and Son, {Sang Hyun} and Youngjoo Byun",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.bioorg.2019.102990",
language = "English (US)",
volume = "89",
journal = "Bioorganic Chemistry",
issn = "0045-2068",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Design and synthesis of dye-conjugated hepsin inhibitors

AU - Kim, Kyul

AU - Kwon, Hongmok

AU - Choi, Doyoung

AU - Lim, Taehyeong

AU - Minn, Il

AU - Son, Sang Hyun

AU - Byun, Youngjoo

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Hepsin is a type II serine protease that is highly expressed in neoplastic prostate. It is an attractive biomarker for imaging metastatic prostate cancer because of its overexpression in advanced prostate cancer and the location of its active site on the cell surface. We designed and synthesized novel hepsin-targeted imaging probes by conjugating the hepsin-binding ligand with near-infrared (NIR) optical dyes. The Leu-Arg dipeptides, attached to BODIPY or SulfoCy7, exhibited strong hepsin-inhibitory activities with Ki values of 21 and 22 nM, respectively. Compound 2 showed selective uptake and retention in hepsin-overexpressing cells. This is the first report of hepsin-targeted optical probes with strong binding affinities and high selectivity over matriptase. Compound 2 has the potential to be used for developing hepsin-based imaging probes and be as a prototype molecule in the design of new hepsin inhibitors.

AB - Hepsin is a type II serine protease that is highly expressed in neoplastic prostate. It is an attractive biomarker for imaging metastatic prostate cancer because of its overexpression in advanced prostate cancer and the location of its active site on the cell surface. We designed and synthesized novel hepsin-targeted imaging probes by conjugating the hepsin-binding ligand with near-infrared (NIR) optical dyes. The Leu-Arg dipeptides, attached to BODIPY or SulfoCy7, exhibited strong hepsin-inhibitory activities with Ki values of 21 and 22 nM, respectively. Compound 2 showed selective uptake and retention in hepsin-overexpressing cells. This is the first report of hepsin-targeted optical probes with strong binding affinities and high selectivity over matriptase. Compound 2 has the potential to be used for developing hepsin-based imaging probes and be as a prototype molecule in the design of new hepsin inhibitors.

KW - BODIPY

KW - Hepsin

KW - Optical dye

KW - SulfoCy7

UR - http://www.scopus.com/inward/record.url?scp=85066075641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066075641&partnerID=8YFLogxK

U2 - 10.1016/j.bioorg.2019.102990

DO - 10.1016/j.bioorg.2019.102990

M3 - Article

C2 - 31136899

AN - SCOPUS:85066075641

VL - 89

JO - Bioorganic Chemistry

JF - Bioorganic Chemistry

SN - 0045-2068

M1 - 102990

ER -